Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations

N Hopkins P; M Krempf; E Bruckert; G Luc; S Donahue; F Yang; Y Zhang; T Dicioccio A

Conference Papers Year : 2018

Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations

, (1) , (2, 3) , , , , (4) ,

1
2
3
4

N Hopkins P

Function : Author

M Krempf

Function : Author

Hôpital Guillaume et René Laennec - Centre Hospitalier Universitaire de Nantes

E Bruckert

Function : Author

CHU Pitié-Salpêtrière [AP-HP]

Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases

G Luc

Function : Author

S Donahue

Function : Author

F Yang

Function : Author

Y Zhang

Function : Author

Institut Parisien de Chimie Moléculaire

T Dicioccio A

Function : Author

Domains

Life Sciences [q-bio]

Maryse Guerin : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03970061

Submitted on : Thursday, February 2, 2023-3:49:54 PM

Last modification on : Thursday, April 11, 2024-1:08:14 PM

Dates and versions

hal-03970061 , version 1 (02-02-2023)

Identifiers

HAL Id : hal-03970061 , version 1

Cite

N Hopkins P, M Krempf, E Bruckert, G Luc, S Donahue, et al.. Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations. Congress of the European-Society-of-Cardiology, Aug 2018, Munich (Allemagne), Germany. ⟨hal-03970061⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS IPCM ICAN INC-CNRS SORBONNE-UNIVERSITE SU-MEDECINE SU-SCIENCES CHIMIE-SU IHU_ICAN

9 View

0 Download

Pharmacokinetics and pharmacodynamics of alirocumab in patients with autosomal dominant hypercholesterolemia associated with PCSK9 gain-of-function or ApoB loss-of-function mutations

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share